Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001258345.3(PACRGL):c.109C>A(p.Gln37Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000657 in 152,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.109C>A (p.Q37K) alteration is located in exon 3 (coding exon 2) of the PACRGL gene. This alteration results from a C to A substitution at nucleotide position 109, causing the glutamine (Q) at amino acid position 37 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
.;Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);Gain of methylation at Q37 (P = 0.0074);